You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proteasome activation

Showing 1 - 25 of 4,932
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aging, Well Aging, Oxidative Stress Trial in Athens (HealthSpan, Placebo)

Completed
  • Aging
  • +2 more
  • HealthSpan
  • Placebo
  • Athens, Attica, Greece
    Institute of Chemical Biology of National Hellenic Research Foun
Jan 8, 2022

Mechanical Ventilation on Diaphragm in COVID-19 Intensive Care

Recruiting
  • Diaphragm Injury
  • +3 more
    • Udine, Italy
    • +1 more
    Jan 11, 2022

    Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

    Completed
    Has Results
    • Acute Leukemia
    • +4 more
    • Atlanta, Georgia
      Northside Hospital
    Sep 1, 2021

    Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

    Recruiting
    • Bortezomib
    • +5 more
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Oct 28, 2022

    Cardiovascular Complications of Carfilzomib Treatment

    Active, not recruiting
    • Multiple Myeloma
      • Athens, Greece
        Department of Clinical Therapeutics, "Alexandra" General Hospita
      Apr 27, 2021

      Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

      Completed
      Has Results
      • Relapsed and/or Refractory Multiple Myeloma
      • Kamogawa, Chiba, Japan
      • +22 more
      Jul 27, 2022

      Nutritional State and Respiratory Muscle Weakness in Adult

      Active, not recruiting
      • Bronchiectasis
        • Assiut, Egypt
          Faculty of medicine, Assiut University
        Aug 13, 2023

        Mantle-Cell Lymphoma Trial in United States (Ixazomib, Ibrutinib)

        Active, not recruiting
        • Mantle-Cell Lymphoma
        • Atlanta, Georgia
        • +13 more
        Nov 17, 2022

        Multiple Myeloma Trial in Hangzhou (Ixazomib plus low-dose lenalidomide, Ixazomib)

        Recruiting
        • Multiple Myeloma
        • Ixazomib plus low-dose lenalidomide
        • Ixazomib
        • Hangzhou, Zhejiang, China
          Yang Xu
        Feb 9, 2023

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

        Recruiting
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Des Moines, Iowa
        • +8 more
        Jan 12, 2023

        Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

        Active, not recruiting
        • Multiple Myeloma
        • High-Risk Cancer
        • Bortezomib following nonmyeloablative allogeneic transplant
        • Montreal, Quebec, Canada
          Hôpital Maisonneuve-Rosemont
        Aug 22, 2022

        Multiple Myeloma Trial in Little Rock (Ixazomib)

        Completed
        Has Results
        • Multiple Myeloma
        • Little Rock, Arkansas
          University of Arkansas for Medical Science
        May 17, 2021

        Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a

        Recruiting
        • Autoimmune Hemolytic Anemia
        • Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
        • combination of a single dose anti-CD20 antibody and bortezomib
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Oct 12, 2021

        Advanced Cancers Trial in Guangzhou, Changsha (TQB3602 Capsule + AK105 Injection)

        Not yet recruiting
        • Advanced Cancers
        • TQB3602 Capsule + AK105 Injection
        • Guangzhou, Guangdong, China
        • +1 more
        Apr 12, 2022

        Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

        Recruiting
        • Multiple Myeloma
        • Athens, Greece
        • +1 more
        Jan 2, 2023

        Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

        Completed
        • Relapse/Refractory Multiple Myeloma
        • Beijing, Beijing, China
        • +16 more
        Jul 27, 2022

        Type 2 Diabetes, Telomere Shortening Trial in Athens (Pythagorean Self-Awareness Intervention(PSAI))

        Completed
        • Type 2 Diabetes Mellitus
        • Telomere Shortening
        • Pythagorean Self-Awareness Intervention(PSAI)
        • Athens, Greece
          General University Laiko Hospital
        Feb 18, 2021

        Multiple Myeloma Trial in Canton (Lenalidomide)

        Recruiting
        • Multiple Myeloma
        • Canton, Ohio
          Gabrail Cancer & Research Center
        Oct 11, 2023

        Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

        Recruiting
        • Kidney Transplantation
        • End Stage Kidney Disease (ESRD)
        • Belatacept Injection
        • Chicago, Illinois
          University of Chicago
        May 13, 2022

        Quality of Life in Relapsed and/or Refractory Multiple Myeloma

        Active, not recruiting
        • Multiple Myeloma
          • Morrisville, North Carolina
            Local Institution
          May 12, 2022

          Relapsed/Refractory Multiple Myeloma Trial in Worldwide (Placebo, Bortezomib, Dexamethasone)

          Completed
          • Relapsed/Refractory Multiple Myeloma
          • Placebo
          • +3 more
          • Aurora, Colorado
          • +96 more
          Aug 22, 2022

          Corneal Toxicity in Patients Treated by Belantamab Mafodotin

          Completed
          • Myeloma Multiple
          • Collection of datas
          • Dijon, France
          • +9 more
          May 31, 2023

          Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

          Withdrawn
          • Relapsed Multiple Myeloma
          • Refractory Multiple Myeloma
          • Elotuzumab, Selinexor, and Dexamethasone (ESd)
          • (no location specified)
          Apr 27, 2022

          Depression Trial in Stockholm (Behavioral activation and emotion-focused interventions)

          Not yet recruiting
          • Depression
          • Behavioral activation and emotion-focused interventions
          • Stockholm, Sweden
            Liljeholmens primary care centre
          Sep 4, 2023

          Rotator Cuff Tear Severity and Scapular and Rotator Cuff Muscle

          Recruiting
          • Rotator Cuff Tears
          • +2 more
          • Surface Electromyography (sEMG) Assessment
          • Al Ḩayy Ath Thāmin, Giza, Egypt
            Outpatient clinic of faculty of physical therapy, Ahram Canadian
          Jul 7, 2023